Vaxart (VXRT) director Kevin Finney granted 39,400 shares and 78,700 options
Rhea-AI Filing Summary
Vaxart director Kevin Finney reported equity awards dated July 16, 2026. He received 39,400 shares of Common Stock upon vesting of restricted stock units, bringing his direct holdings to 244,171 shares. He was also granted 78,700 stock options with a $0.5149 exercise price, expiring July 16, 2036. Both the RSU shares and options vest on the earlier of the date immediately prior to Vaxart’s 2027 annual meeting of stockholders and July 16, 2027, the first anniversary of the grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 39,400 shares
Net Buy
2 txns
Insider
Finney Kevin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Options (right to buy) F2 | 78,700 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 39,400 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Options (right to buy) — 78,700 shares (Direct);
Common Stock — 244,171 shares (Direct)
Footnotes (2)
- F1. Grant of shares upon vesting of restricted stock units. The shares underlying the award shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary date of the grant.
- F2. The shares subject to this option shall vest on the earlier of the date immediately prior of the 2027 annual meeting of stockholders of the Issuer and July 16, 2027, the first anniversary of the date of the grant.
Key Figures
RSU shares vested: 39,400 shares of Common Stock
Shares held after award: 244,171 shares of Common Stock
Stock options granted: 78,700 options
+3 more
6 metrics
RSU shares vested
39,400 shares of Common Stock
Grant of shares upon vesting of restricted stock units on July 16, 2026
Shares held after award
244,171 shares of Common Stock
Direct holdings following RSU share grant
Stock options granted
78,700 options
Stock Options (right to buy) granted on July 16, 2026
Option exercise price
$0.5149 per share
Conversion or exercise price for 78,700 stock options
Option expiration
July 16, 2036
Expiration date of the 78,700 stock options
Vesting date outer limit
July 16, 2027
First anniversary of grant; latest vesting date for RSUs and options
Key Terms
restricted stock units, Stock Options (right to buy, vest, annual meeting of stockholders
4 terms
restricted stock units financial
"Grant of shares upon vesting of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Options (right to buy financial
"Stock Options (right to buy) granted for 78,700 shares."
vest financial
"The shares underlying the award shall vest on the earlier of the date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
annual meeting of stockholders financial
"earlier of the date immediately prior of the 2027 annual meeting of stockholders"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Kevin Finney report for Vaxart (VXRT) on July 16, 2026?
Kevin Finney reported two equity awards: 39,400 newly vested shares of Common Stock and 78,700 stock options. The awards are part of his director compensation and follow specified vesting conditions tied to Vaxart’s 2027 annual meeting and the grant’s first anniversary.
What stock options did Kevin Finney receive from Vaxart (VXRT) and at what exercise price?
Kevin Finney received 78,700 stock options to buy Vaxart Common Stock at an exercise price of $0.5149 per share. These options represent additional potential ownership, subject to vesting conditions and exercisable before their stated expiration date in 2036.
What is the expiration date of Kevin Finney’s newly granted Vaxart (VXRT) stock options?
The newly granted stock options to Kevin Finney expire on July 16, 2036. He may exercise up to 78,700 options at $0.5149 per share, provided the options have vested under the stated 2027 vesting schedule.